These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 34845645

  • 1. Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson's disease in Chinese patients.
    Xu Q, Lai Q, Wang J, Zhuang L, Cheng L, Mo Y, Liu L, Zhao Z, Zhang Y, Weng S, Qiao S.
    Acta Neurol Belg; 2022 Dec; 122(6):1557-1566. PubMed ID: 34845645
    [Abstract] [Full Text] [Related]

  • 2. Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility.
    Oh J, An HJ, Kim JO, Jun HH, Kim WR, Kim EJ, Oh D, Kim JW, Kim NK.
    Int J Mol Sci; 2020 Jun 18; 21(12):. PubMed ID: 32570732
    [Abstract] [Full Text] [Related]

  • 3. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.
    Jeon YJ, Kim YR, Lee BE, Choi YS, Kim JH, Shin JE, Rah H, Cha SH, Lee WS, Kim NK.
    Thromb Haemost; 2013 Oct 18; 110(4):742-50. PubMed ID: 23903286
    [Abstract] [Full Text] [Related]

  • 4. Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Yang Z, Xue L, Li C, Li M, Xie A.
    Neurosci Lett; 2022 Jul 27; 784():136734. PubMed ID: 35709878
    [Abstract] [Full Text] [Related]

  • 5. Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease.
    Jin J, Xue L, Bai X, Zhang X, Tian Q, Xie A.
    Neurosci Lett; 2020 Sep 25; 736():135273. PubMed ID: 32712352
    [Abstract] [Full Text] [Related]

  • 6. CD33 polymorphisms and Parkinson's disease Parkinson's disease in northern Chinese Han population: A case-control study.
    Tian Q, Sun X, Li C, Yang Y, Hou B, Xie A.
    Neurosci Lett; 2023 Aug 24; 812():137400. PubMed ID: 37479176
    [Abstract] [Full Text] [Related]

  • 7. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.
    Kim H, Cho C, Cho Y, Cho S, Yoon K, Kim K.
    BMC Musculoskelet Disord; 2011 Jul 14; 12():160. PubMed ID: 21752301
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of ATG5 gene polymorphism with Parkinson's disease in a Han Chinese population.
    Han J, Feng G, Wu J, Zhang Y, Long Z, Yao X.
    Acta Neurol Belg; 2022 Aug 14; 122(4):1049-1056. PubMed ID: 34661876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of AQP4 single nucleotide polymorphisms (rs335929 and rs2075575) with Parkinson's disease: A case-control study.
    Sun X, Tian Q, Yang Z, Liu Y, Li C, Hou B, Xie A.
    Neurosci Lett; 2023 Feb 16; 797():137062. PubMed ID: 36626962
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease.
    Su S, Chen S, Zhao J, Huang J, Wang X, Chen R, Gu D.
    Arterioscler Thromb Vasc Biol; 2006 Apr 16; 26(4):948-54. PubMed ID: 16424345
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the relationship between SORL1 gene polymorphism and Parkinson's disease in the Chinese population.
    Wang Y, Luan M, Xue L, Jin J, Xie A.
    Neurosci Lett; 2022 May 01; 778():136602. PubMed ID: 35364126
    [Abstract] [Full Text] [Related]

  • 14. Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chinese women.
    Huang X, Li Y, Huang Z, Wang C, Xu Z.
    J Mol Neurosci; 2014 Dec 01; 54(4):803-10. PubMed ID: 25231632
    [Abstract] [Full Text] [Related]

  • 15. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
    Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, Chou MC, Liu KC, Yang SF, Yi YC.
    J Surg Oncol; 2011 Dec 01; 104(7):755-9. PubMed ID: 21761413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study.
    Morange PE, Saut N, Alessi MC, Yudkin JS, Margaglione M, Di Minno G, Hamsten A, Humphries SE, Tregouet DA, Juhan-Vague I.
    Arterioscler Thromb Vasc Biol; 2007 Oct 01; 27(10):2250-7. PubMed ID: 17656673
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
    Wang J, Peng Y, Guo H, Li C.
    Technol Cancer Res Treat; 2021 Oct 01; 20():15330338211037813. PubMed ID: 34521295
    [Abstract] [Full Text] [Related]

  • 20. Genetic polymorphisms in plasminogen activator inhibitor-1 predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese population.
    Zhang Y, Wang R, Li S, Kong X, Wang Z, Chen W, Lin N.
    Diagn Pathol; 2013 Oct 17; 8():169. PubMed ID: 24135164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.